(Q37622105)

21 August 2017

1 reference

title

Precursors of endometrial and ovarian carcinoma (English)

1 reference

21 August 2017

Robert J Kurman

1

1 reference

PubMed ID

19859732

21 August 2017

Thomas G McConnell

series ordinal

2

1 reference

21 August 2017

27 October 2009

1 reference

21 August 2017

1 reference

21 August 2017

456

1 reference

21 August 2017

1-12

1 reference

21 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-009-0824-9

21 August 2017

0 references

cites work

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-009-0824-9

Pten, a protean tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-009-0824-9

The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-009-0824-9

Mutations of the beta-catenin gene in endometrial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-009-0824-9

Diverse tumorigenic pathways in ovarian serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-009-0824-9

Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis

21 January 2018

1 reference

12 December 2020

K-ras activation in premalignant and malignant epithelial lesions of the human uterus

1 reference

12 December 2020

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

1 reference

12 December 2020

PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma

1 reference

12 December 2020

p53 gene mutations and protein accumulation in human ovarian cancer

1 reference

12 December 2020

Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma

1 reference

12 December 2020

Papillary serous adenocarcinoma of the endometrium: A clinicopathologic study of 19 cases

1 reference

12 December 2020

Endometrial hyperplasia: is it time for a quantum leap to a new classification?

1 reference

12 December 2020

Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms

1 reference

12 December 2020

Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust.

1 reference

12 December 2020

Serous carcinogenesis in the fallopian tube: a descriptive classification.

1 reference

12 December 2020

Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.

1 reference

12 December 2020

Uterine papillary serous carcinoma: patterns of metastatic spread

1 reference

12 December 2020

Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications

1 reference

12 December 2020

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features

1 reference

12 December 2020

Histologic transformation of benign endometriosis to early epithelial ovarian cancer

1 reference

12 December 2020

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

1 reference

12 December 2020

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

1 reference

12 December 2020

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

1 reference

12 December 2020

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma

1 reference

12 December 2020

p53 protein expression in putative precursor lesions of epithelial ovarian cancer.

1 reference

12 December 2020

Clinical implications of the p53 tumor-suppressor gene

1 reference

12 December 2020

K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary

1 reference

12 December 2020

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

1 reference

12 December 2020

The lipid phosphatase activity of PTEN is critical for its tumor supressor function

1 reference

12 December 2020

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

1 reference

12 December 2020

Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification

1 reference

12 December 2020

Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators

1 reference

12 December 2020

Tubal (serous) carcinoma of the endometrium

1 reference

12 December 2020

Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia

1 reference

12 December 2020

KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants

1 reference

12 December 2020

Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

1 reference

12 December 2020

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

1 reference

12 December 2020

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

12 December 2020

Microsatellite instability in sporadic endometrial carcinoma

1 reference

12 December 2020

Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases

1 reference

12 December 2020

Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification

1 reference

12 December 2020

Further evaluation of the practical applicability of nuclear morphometry for the prediction of the outcome of atypical endometrial hyperplasia

1 reference

12 December 2020

Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium

1 reference

12 December 2020

Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors

1 reference

12 December 2020

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.

1 reference

12 December 2020

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

1 reference

12 December 2020

Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

1 reference

12 December 2020

Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors

1 reference

12 December 2020

Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features

1 reference

12 December 2020

K-ras mutations in nonmucinous ovarian epithelial tumors: a molecular analysis and clinicopathologic study of 144 patients

1 reference

12 December 2020

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.

1 reference

12 December 2020

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

1 reference

12 December 2020

Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary

1 reference

12 December 2020

Endometriosis and ovarian cancer

1 reference

12 December 2020

High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.

1 reference

12 December 2020

Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance

1 reference

12 December 2020

Ovarian atypical endometriosis: its close association with malignant epithelial tumours

1 reference

12 December 2020

Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas

1 reference

12 December 2020

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer

1 reference

12 December 2020

Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group

1 reference

12 December 2020

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

1 reference

12 December 2020

Two pathogenetic types of endometrial carcinoma

1 reference

12 December 2020

Early de novo ovarian carcinoma. A study of fourteen cases.

1 reference

12 December 2020

The pathological assessment of ovarian neoplasms. i: introduction to the common ‘epithelial’ tumours and analysis of benign ‘epithelial’ tumours

1 reference

12 December 2020

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma

1 reference

12 December 2020

Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma

1 reference

12 December 2020

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

12 December 2020

Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

12 December 2020

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

1 reference

12 December 2020

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

1 reference

12 December 2020

Discrimination of hyperplasia and carcinoma of the endometrium by quantitative microscopy--a feasibility study

1 reference

12 December 2020

A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens

1 reference

12 December 2020

Microsatellite instability in endometrial carcinoma

1 reference

12 December 2020

Genetic alterations during colorectal-tumor development

1 reference

12 December 2020

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

1 reference

12 December 2020

Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma

1 reference

12 December 2020

Molecular genetic defects in endometriosis.

1 reference

12 December 2020

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

1 reference

12 December 2020

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

1 reference

12 December 2020

Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma

1 reference

12 December 2020

Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias

1 reference

12 December 2020

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

12 December 2020

Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies

1 reference

12 December 2020

Precursors of endometrial clear cell carcinoma

1 reference

12 December 2020

10.1007/S00428-009-0824-9

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19859732